← Back to Search

Care Ecosystem for Dementia

N/A
Waitlist Available
Led By Katherine L Possin, PhD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Have a dementia diagnosis documented in the EHR
Age 18+
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 12 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will evaluate how an accessible, team-based dementia care program can improve outcomes for patients, caregivers, and healthcare providers during the pandemic.

Who is the study for?
This trial is for adults with various types of progressive dementia, including Alzheimer's, who live at home and have a primary caregiver willing to participate. They must not be in long-term care facilities, should agree to join the Care Ecosystem program and complete surveys. Those previously enrolled in the program or without accessible health records are excluded.
What is being tested?
The study tests the 'Care Ecosystem,' a remote care model delivered by phone and web designed to support patients with dementia and their caregivers. It aims to improve patient quality of life, reduce emergency visits, lower caregiver depression, and cut inappropriate medication use.
What are the potential side effects?
Since this intervention involves non-medical support rather than drugs or medical procedures, traditional side effects aren't expected. However, there may be indirect impacts on stress levels or emotional well-being that will be monitored.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My medical records show a dementia diagnosis.
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in caregiver depression
Change in emergency department (ED) visits
Change in potentially inappropriate medications for dementia or cognitive impairment
+1 more
Secondary study objectives
Change in PWD annual bed days
Change in PWD hospitalizations
Change in caregiver anxiety
+3 more
Other study objectives
Modifications of anti-dementia medications

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Care EcosystemExperimental Treatment1 Intervention
Patient and caregiver dyads receive the Care Ecosystem intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Care Ecosystem
2020
N/A
~530

Find a Location

Who is running the clinical trial?

National Institute on Aging (NIA)NIH
1,788 Previous Clinical Trials
28,181,963 Total Patients Enrolled
University of California, San FranciscoLead Sponsor
2,586 Previous Clinical Trials
14,897,496 Total Patients Enrolled
Ochsner Health SystemOTHER
95 Previous Clinical Trials
87,350 Total Patients Enrolled

Media Library

Care Ecosystem Clinical Trial Eligibility Overview. Trial Name: NCT05669365 — N/A
Alzheimer's Dementia Research Study Groups: Care Ecosystem
Alzheimer's Dementia Clinical Trial 2023: Care Ecosystem Highlights & Side Effects. Trial Name: NCT05669365 — N/A
Care Ecosystem 2023 Treatment Timeline for Medical Study. Trial Name: NCT05669365 — N/A
~947 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top